These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
561 related articles for article (PubMed ID: 25996389)
1. Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India. Sachdeva KS; Raizada N; Sreenivas A; Van't Hoog AH; van den Hof S; Dewan PK; Thakur R; Gupta RS; Kulsange S; Vadera B; Babre A; Gray C; Parmar M; Ghedia M; Ramachandran R; Alavadi U; Arinaminpathy N; Denkinger C; Boehme C; Paramasivan CN PLoS One; 2015; 10(5):e0126065. PubMed ID: 25996389 [TBL] [Abstract][Full Text] [Related]
2. Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB. Raizada N; Sachdeva KS; Nair SA; Kulsange S; Gupta RS; Thakur R; Parmar M; Gray C; Ramachandran R; Vadera B; Ekka S; Dhawan S; Babre A; Ghedia M; Alavadi U; Dewan P; Khetrapal M; Khanna A; Boehme C; Paramsivan CN PLoS One; 2014; 9(8):e105346. PubMed ID: 25140877 [TBL] [Abstract][Full Text] [Related]
3. Catching the missing million: experiences in enhancing TB & DR-TB detection by providing upfront Xpert MTB/RIF testing for people living with HIV in India. Raizada N; Sachdeva KS; Sreenivas A; Kulsange S; Gupta RS; Thakur R; Dewan P; Boehme C; Paramsivan CN PLoS One; 2015; 10(2):e0116721. PubMed ID: 25658091 [TBL] [Abstract][Full Text] [Related]
4. Piloting Upfront Xpert MTB/RIF Testing on Various Specimens under Programmatic Conditions for Diagnosis of TB & DR-TB in Paediatric Population. Raizada N; Sachdeva KS; Swaminathan S; Kulsange S; Khaparde SD; Nair SA; Khanna A; Chopra KK; Hanif M; Sethi GR; Umadevi KR; Keshav Chander G; Saha B; Shah A; Parmar M; Ghediya M; Jaju J; Boehme C; Paramasivan CN PLoS One; 2015; 10(10):e0140375. PubMed ID: 26469691 [TBL] [Abstract][Full Text] [Related]
5. Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China. Wu Z; Rueda ZV; Li T; Zhang Z; Jiang Y; Sha W; Yu F; Chen J; Pan Q; Shen X; Yuan Z BMC Infect Dis; 2020 Feb; 20(1):153. PubMed ID: 32070292 [TBL] [Abstract][Full Text] [Related]
6. Real-Life Clinical Practice of Using the Xpert MTB/RIF Assay in Thailand. Kawkitinarong K; Suwanpimolkul G; Kateruttanakul P; Manosuthi W; Ubolyam S; Sophonphan J; Avihingsanon A; Ruxrungtham K Clin Infect Dis; 2017 May; 64(suppl_2):S171-S178. PubMed ID: 28475796 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734 [TBL] [Abstract][Full Text] [Related]
8. Effect of Xpert MTB/RIF on the treatment of multi-drug-resistant or rifampicin-resistant tuberculosis screened out from re-treatment pulmonary tuberculosis patients, a prospective cohort study. Wang P; Gu J; Yang J; Yang C; Wu X; Yu F; Fan L Ann Palliat Med; 2020 Mar; 9(2):239-246. PubMed ID: 32233619 [TBL] [Abstract][Full Text] [Related]
9. Active case finding of rifampicin sensitive and resistant TB among household contacts of drug resistant TB patients in Andhra Pradesh and Telangana states of India - A systematic screening intervention. Chatla C; Jaju J; Achanta S; Samyuktha R; Chakramahanti S; Purad C; Chepuri R; Nair SA; Parmar M Indian J Tuberc; 2018 Jul; 65(3):218-224. PubMed ID: 29933863 [TBL] [Abstract][Full Text] [Related]
10. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania. Pimkina E; Zablockis R; Nikolayevskyy V; Danila E; Davidaviciene E Respir Med; 2015 Nov; 109(11):1484-9. PubMed ID: 26403251 [TBL] [Abstract][Full Text] [Related]
11. Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial. Durovni B; Saraceni V; van den Hof S; Trajman A; Cordeiro-Santos M; Cavalcante S; Menezes A; Cobelens F PLoS Med; 2014 Dec; 11(12):e1001766. PubMed ID: 25490549 [TBL] [Abstract][Full Text] [Related]
12. Use of the Xpert(®) MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, Zambia. Bates M; Ahmed Y; Chilukutu L; Tembo J; Cheelo B; Sinyangwe S; Kapata N; Maeurer M; O'Grady J; Mwaba P; Zumla A Trop Med Int Health; 2013 Sep; 18(9):1134-1140. PubMed ID: 23834035 [TBL] [Abstract][Full Text] [Related]
13. Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin. Pillay S; Steingart KR; Davies GR; Chaplin M; De Vos M; Schumacher SG; Warren R; Theron G Cochrane Database Syst Rev; 2022 May; 5(5):CD014841. PubMed ID: 35583175 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study. Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495 [TBL] [Abstract][Full Text] [Related]
15. Rapid detection of Mycobacterium tuberculosis and rifampicin resistance in extrapulmonary tuberculosis and sputum smear-negative pulmonary suspects using Xpert MTB/RIF. Ullah I; Javaid A; Masud H; Ali M; Basit A; Ahmad W; Younis F; Yasmin R; Khan A; Jabbar A; Husain M; Butt ZA J Med Microbiol; 2017 Apr; 66(4):412-418. PubMed ID: 28425873 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy and turnaround time of the Xpert MTB/RIF assay in routine clinical practice. Kwak N; Choi SM; Lee J; Park YS; Lee CH; Lee SM; Yoo CG; Kim YW; Han SK; Yim JJ PLoS One; 2013; 8(10):e77456. PubMed ID: 24204834 [TBL] [Abstract][Full Text] [Related]
17. Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis. Zifodya JS; Kreniske JS; Schiller I; Kohli M; Dendukuri N; Schumacher SG; Ochodo EA; Haraka F; Zwerling AA; Pai M; Steingart KR; Horne DJ Cochrane Database Syst Rev; 2021 Feb; 2():CD009593. PubMed ID: 33616229 [TBL] [Abstract][Full Text] [Related]
18. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. Lawn SD; Brooks SV; Kranzer K; Nicol MP; Whitelaw A; Vogt M; Bekker LG; Wood R PLoS Med; 2011 Jul; 8(7):e1001067. PubMed ID: 21818180 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia. Sinshaw W; Kebede A; Bitew A; Tesfaye E; Tadesse M; Mehamed Z; Yenew B; Amare M; Dagne B; Diriba G; Alemu A; Getahun M; Fikadu D; Desta K; Tola HH BMC Infect Dis; 2019 Jul; 19(1):641. PubMed ID: 31324227 [TBL] [Abstract][Full Text] [Related]
20. Retrospective Diagnostic Accuracy Study of Abbott RealTi Howlett P; Nabeta P; Tukvadze N; Schumacher SG; Denkinger CM Microbiol Spectr; 2021 Sep; 9(1):e0013221. PubMed ID: 34406811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]